Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Gainers

Cellectis S.A. CLLS shares surged 152% to $2.43 in pre-market trading. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting.

GDEV Inc. GDEV shares rose 26.2% to $2.55 in pre-market trading after falling 11% on Tuesday.

Sientra, Inc. SIEN shares rose 24.7% to $0.7980 in pre-market trading. Sientra shares fell 56% on Tuesday after the company withdrew its FY23 guidance and reported interim third-quarter financial results.

Bruush Oral Care Inc. BRSH rose 16.6% to $0.2751 in pre-market trading after falling 17% on Tuesday.

Fujian Blue Hat Interactive Entertainment Technology Ltd. BHAT shares climbed 15% to $0.9999 in pre-market trading after falling 10% on Tuesday.

NOVONIX Limited NVX shares gained 14.8% to $2.10 in pre-market trading. NOVONIX said its NOVONIX Anode Materials division finalized its $100 million grant award from the U.S. Department of Energy.

Society Pass Incorporated SOPA shares jumped 14.1% to $0.4297 in pre-market trading.

DBV Technologies S.A. DBVT rose 11.8% to $1.13 in pre-market trading after the company announced the receipt of written feedback from the U.S. FDA regarding the remaining study design elements for the COMFORT supplemental safety studies. The company also reported results for the third quarter.

Plus Therapeutics, Inc. PSTV shares rose 11.3% to $1.37 in pre-market trading after the company reported third-quarter financial results and announced a share repurchase program.

FLJ Group Limited FLJ gained 9.3% to $0.2733 in pre-market trading. FLJ Group reported disposal of long-term apartment rental business.

Losers

WeWork Inc. WE dipped 37.3% to $1.43 in pre-market trading. According to a Wall Street Journal report citing people familiar with the matter, WeWork plans to file for Chapter 11 bankruptcy in New Jersey as soon as next week.

Paycom Software, Inc. PAYC shares fell 37.1% to $154.15 in pre-market trading after the company reported worse-than-expected third-quarter sales results and issued FY23 revenue guidance below estimates. Several analysts also downgraded the stock today.

Tonix Pharmaceuticals Holding Corp. TNXP shares fell 30.5% to $0.41 in pre-market trading after the company reported topline results from Phase 2 proof-of-concept study of TNX-601 ER for the treatment of major depressive disorder.

Big 5 Sporting Goods Corporation BGFV shares fell 16.6% to $5.89 in pre-market trading after the company reported weaker-than-expected results for its third quarter.

Tempo Automation Holdings, Inc. TMPO shares fell 13.6% to $0.0717 in pre-market trading after dipping 30% on Tuesday.

Brainstorm Cell Therapeutics Inc. BCLI fell 13.3% to $0.1326 in pre-market trading.

Yum China Holdings, Inc. YUMC shares fell 12.4% to $46.00 in pre-market trading after the company reported worse-than-expected financial results for its third quarter.

BAIYU Holdings, Inc. BYU fell 12% to $1.83 in pre-market after dipping 19% on Tuesday.

Lexicon Pharmaceuticals, Inc. LXRX fell 11.2% to $1.10 in pre-market trading. Lexicon Pharmaceuticals said Matthew Cullen is joining the company as vice president of value and access, effective Nov. 1, 2023, and Lisa DeFrancesco will join as head of investor relations and corporate strategy, effective Nov. 13, 2023.

Recon Technology, Ltd. RCON shares fell 9.9% to $0.2081 in pre-market trading. The company recently said total revenue fell 19.9% to RMB67.1 million ($9.3 million) for the year ended June 30, 2023.

Now Read This: QUALCOMM Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts